Aarti Pharmalabs Limited (BOM:543748)

Market Cap	72.18B
Revenue (ttm)	21.25B
Net Income (ttm)	2.72B
Shares Out	n/a
EPS (ttm)	30.04
PE Ratio	26.50
Forward PE	n/a
Dividend	3.50 (0.47%)
Ex-Dividend Date	Feb 14, 2025

Volume	29,332
Average Volume	27,665
Open	725.05
Previous Close	736.95
Day's Range	725.05 - 775.00
52-Week Range	486.30 - 837.00
Beta	n/a
RSI	60.42
Earnings Date	May 12, 2025

About Aarti Pharmalabs

Aarti Pharmalabs Limited, together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system (CNS) agents, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medication...

• Industry: Pharmaceutical Preparations
• Founded: 2019
• Employees: 2,095
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543748

Financial Performance

In 2024, Aarti Pharmalabs's revenue was 21.25 billion, an increase of 14.71% compared to the previous year's 18.53 billion. Earnings were 2.72 billion, an increase of 25.59%.